Gland Pharma Ltd.
•₹ 2,819.3-0.02%
2026-08-21
PROS
- Company is almost debt free
- Company has consistently been profitable over the last 5 years
- Latest quarter profit grew 47.1% YoY, showing strong momentum
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.18x)
- Company has been maintaining a healthy dividend payout of 32.1%
CONS
- Company has a low return on equity of 9.2% over last 3 years
- Company has delivered a poor profit growth of 0.6% over past five years
- Operating margins have contracted to 25.3% from 34.9%
- Expensive relative to growth - PEG of 4.3
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | GLAND | 2842.65 | 41.54 | 46894.25 | 0.70 | 316.96 | 47.09 | 1800.27 | 19.57 | 14.96 | 27.18 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,209 | 1,373 | 1,545 | 1,537 | 1,402 | 1,406 | 1,384 | 1,425 | 1,506 | 1,487 | 1,695 | 1,743 | 1,800 | |
| 915 | 1,049 | 1,189 | 1,179 | 1,137 | 1,109 | 1,024 | 1,077 | 1,138 | 1,173 | 1,260 | 1,230 | 1,427 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 38 | 53 | 37 | 42 | 51 | 60 | 58 | 44 | 58 | 84 | 63 | 111 | 61 |
| Interest | 5 | 6 | 5 | 10 | 6 | 6 | 23 | 7 | 12 | 8 | 4 | 10 | 4 |
| Depreciation | 65 | 81 | 105 | 93 | 92 | 94 | 96 | 96 | 101 | 106 | 108 | 109 | 111 |
| 261 | 290 | 283 | 298 | 218 | 257 | 299 | 288 | 313 | 284 | 362 | 506 | 435 | |
| Tax % | 25.71% | 33.05% | 32.24% | 35.48% | 34.13% | 36.32% | 31.61% | 35.30% | 31.10% | 35.30% | 27.79% | 27.50% | 27.13% |
| Net Profit | 0 | 0 | 0 | 0 | 144 | 164 | 205 | 187 | 215 | 184 | 261 | 367 | 317 |
| 12 | 12 | 12 | 12 | 9 | 10 | 12 | 11 | 13 | 11 | 16 | 22 | 2 | |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 1,209
- 915
- Operating Profit
- —
- OPM %
- —
- Other Income
- 38
- Interest
- 5
- Depreciation
- 65
- 261
- Tax %
- 25.71%
- Net Profit
- 0
- 12
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 1,373
- 1,049
- Operating Profit
- —
- OPM %
- —
- Other Income
- 53
- Interest
- 6
- Depreciation
- 81
- 290
- Tax %
- 33.05%
- Net Profit
- 0
- 12
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 1,545
- 1,189
- Operating Profit
- —
- OPM %
- —
- Other Income
- 37
- Interest
- 5
- Depreciation
- 105
- 283
- Tax %
- 32.24%
- Net Profit
- 0
- 12
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 1,537
- 1,179
- Operating Profit
- —
- OPM %
- —
- Other Income
- 42
- Interest
- 10
- Depreciation
- 93
- 298
- Tax %
- 35.48%
- Net Profit
- 0
- 12
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 1,402
- 1,137
- Operating Profit
- —
- OPM %
- —
- Other Income
- 51
- Interest
- 6
- Depreciation
- 92
- 218
- Tax %
- 34.13%
- Net Profit
- 144
- 9
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 1,406
- 1,109
- Operating Profit
- —
- OPM %
- —
- Other Income
- 60
- Interest
- 6
- Depreciation
- 94
- 257
- Tax %
- 36.32%
- Net Profit
- 164
- 10
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 1,384
- 1,024
- Operating Profit
- —
- OPM %
- —
- Other Income
- 58
- Interest
- 23
- Depreciation
- 96
- 299
- Tax %
- 31.61%
- Net Profit
- 205
- 12
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 1,425
- 1,077
- Operating Profit
- —
- OPM %
- —
- Other Income
- 44
- Interest
- 7
- Depreciation
- 96
- 288
- Tax %
- 35.30%
- Net Profit
- 187
- 11
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 1,506
- 1,138
- Operating Profit
- —
- OPM %
- —
- Other Income
- 58
- Interest
- 12
- Depreciation
- 101
- 313
- Tax %
- 31.10%
- Net Profit
- 215
- 13
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 1,487
- 1,173
- Operating Profit
- —
- OPM %
- —
- Other Income
- 84
- Interest
- 8
- Depreciation
- 106
- 284
- Tax %
- 35.30%
- Net Profit
- 184
- 11
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 1,695
- 1,260
- Operating Profit
- —
- OPM %
- —
- Other Income
- 63
- Interest
- 4
- Depreciation
- 108
- 362
- Tax %
- 27.79%
- Net Profit
- 261
- 16
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 1,743
- 1,230
- Operating Profit
- —
- OPM %
- —
- Other Income
- 111
- Interest
- 10
- Depreciation
- 109
- 506
- Tax %
- 27.50%
- Net Profit
- 367
- 22
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 1,800
- 1,427
- Operating Profit
- —
- OPM %
- —
- Other Income
- 61
- Interest
- 4
- Depreciation
- 111
- 435
- Tax %
- 27.13%
- Net Profit
- 317
- 2
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 16
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 2,633 | 3,463 | 4,401 | 3,625 | 5,665 | 5,617 | 6,431 | 6,725 | |
| 1,678 | 2,161 | 2,891 | 2,600 | 4,332 | 4,348 | 4,801 | 5,090 | |
| Operating Profit | 1,095 | 1,437 | 1,734 | 1,265 | 1,503 | 1,483 | 1,946 | — |
| OPM % | 42 | 41 | 39 | 35 | 27 | 26 | 30 | — |
| Other Income | 139 | 135 | 224 | 240 | 170 | 214 | 316 | 320 |
| Interest | 7 | 3 | 5 | 7 | 26 | 42 | 33 | 26 |
| Depreciation | 95 | 99 | 110 | 147 | 345 | 378 | 424 | 434 |
| 993 | 1,335 | 1,619 | 1,055 | 1,133 | 1,063 | 1,465 | 1,587 | |
| Tax % | 22 | 25 | 25 | 26 | 32 | 34 | 30 | 29 |
| Net Profit | 773 | 997 | 1,212 | 781 | 772 | 699 | 1,027 | 1,129 |
| EPS | 50 | 63 | 74 | 47 | 47 | 42 | 62 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 43 | 42 | 32 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 50 | 61 | 74 | 47 | 47 | 42 | 62 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 50 | 61 | 74 | 47 | 47 | 42 | 62 | — |
Mar 2020
- 2,633
- 1,678
- Operating Profit
- 1,095
- OPM %
- 42
- Other Income
- 139
- Interest
- 7
- Depreciation
- 95
- 993
- Tax %
- 22
- Net Profit
- 773
- EPS
- 50
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 50
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 50
Mar 2021
- 3,463
- 2,161
- Operating Profit
- 1,437
- OPM %
- 41
- Other Income
- 135
- Interest
- 3
- Depreciation
- 99
- 1,335
- Tax %
- 25
- Net Profit
- 997
- EPS
- 63
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 61
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 61
Mar 2022
- 4,401
- 2,891
- Operating Profit
- 1,734
- OPM %
- 39
- Other Income
- 224
- Interest
- 5
- Depreciation
- 110
- 1,619
- Tax %
- 25
- Net Profit
- 1,212
- EPS
- 74
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 74
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 74
Mar 2023
- 3,625
- 2,600
- Operating Profit
- 1,265
- OPM %
- 35
- Other Income
- 240
- Interest
- 7
- Depreciation
- 147
- 1,055
- Tax %
- 26
- Net Profit
- 781
- EPS
- 47
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 47
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 47
Mar 2024
- 5,665
- 4,332
- Operating Profit
- 1,503
- OPM %
- 27
- Other Income
- 170
- Interest
- 26
- Depreciation
- 345
- 1,133
- Tax %
- 32
- Net Profit
- 772
- EPS
- 47
- Dividend Payout %
- 43
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 47
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 47
Mar 2025
- 5,617
- 4,348
- Operating Profit
- 1,483
- OPM %
- 26
- Other Income
- 214
- Interest
- 42
- Depreciation
- 378
- 1,063
- Tax %
- 34
- Net Profit
- 699
- EPS
- 42
- Dividend Payout %
- 42
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 42
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 42
Mar 2026
- 6,431
- 4,801
- Operating Profit
- 1,946
- OPM %
- 30
- Other Income
- 316
- Interest
- 33
- Depreciation
- 424
- 1,465
- Tax %
- 30
- Net Profit
- 1,027
- EPS
- 62
- Dividend Payout %
- 32
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 62
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 62
TTM
- 6,725
- 5,090
- Operating Profit
- —
- OPM %
- —
- Other Income
- 320
- Interest
- 26
- Depreciation
- 434
- 1,587
- Tax %
- 29
- Net Profit
- 1,129
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 13%
- 3 Years:
- 21%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 1%
- 3 Years:
- 10%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- -7%
- 3 Years:
- 21%
- 1 Year:
- 45%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 11%
- 3 Years:
- 9%
- Last Year:
- 11%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - |
| Equity Capital | 15 | 16 | 16 | 16 | 16 | 16 | 16 |
| 3,614 | 5,861 | 7,128 | 7,941 | 8,706 | 9,134 | 10,296 | |
| Trade Payables | 249 | 396 | 463 | 587 | 768 | 820 | 834 |
| 207 | 222 | 226 | 233 | 1,121 | 1,202 | 1,302 | |
| Total Liabilities | 4,086 | 6,496 | 7,834 | 8,778 | 10,611 | 11,173 | 12,449 |
| ASSETS | - | - | - | - | - | - | - |
| 968 | 954 | 1,502 | 1,571 | 3,947 | 4,147 | 4,492 | |
| Capital Work in Progress | 188 | 338 | 181 | 177 | 238 | 151 | 342 |
| 0 | 0 | 155 | 0 | 0 | 0 | 0 | |
| 756 | 1,275 | 1,186 | 1,945 | 1,655 | 1,685 | 1,744 | |
| 0 | 0 | 0 | 0 | 1,559 | 1,517 | 1,891 | |
| Cash & Bank | 1,325 | 3,006 | 3,093 | 3,771 | 1,839 | 2,556 | 3,359 |
| 848 | 923 | 1,717 | 1,314 | 1,373 | 1,117 | 620 | |
| Total Assets | 4,086 | 6,496 | 7,834 | 8,778 | 10,611 | 11,173 | 12,449 |
| Total Debt | 5 | 4 | 4 | 4 | 320 | 269 | 243 |
| Net Working Capital | 2,487 | 4,611 | 5,270 | 6,172 | 4,247 | 5,218 | 5,918 |
| Contingent Liabilities | 12 | 75 | 13 | 22 | 16 | 21 | 10 |
| Book Value per Share | 234.25 | 359.30 | 434.84 | 483.12 | 529.56 | 555.40 | 625.91 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 5 | 4 | 4 | 4 | 320 | 269 | 243 |
| Net Working Capital | 2,487 | 4,611 | 5,270 | 6,172 | 4,247 | 5,218 | 5,918 |
| Contingent Liabilities | 12 | 75 | 13 | 22 | 16 | 21 | 10 |
| Book Value per Share | 234.25 | 359.30 | 434.84 | 483.12 | 529.56 | 555.40 | 625.91 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2020
- Equity Capital
- 15
- 3,614
- Trade Payables
- 249
- 207
- Total Liabilities
- 4,086
- 968
- Capital Work in Progress
- 188
- 0
- 756
- 0
- Cash & Bank
- 1,325
- 848
- Total Assets
- 4,086
- Total Debt
- 5
- Net Working Capital
- 2,487
- Contingent Liabilities
- 12
- Book Value per Share
- 234.25
- Face Value
- 1.00
- Total Debt
- 5
- Net Working Capital
- 2,487
- Contingent Liabilities
- 12
- Book Value per Share
- 234.25
- Face Value
- 1.00
Mar 2021
- Equity Capital
- 16
- 5,861
- Trade Payables
- 396
- 222
- Total Liabilities
- 6,496
- 954
- Capital Work in Progress
- 338
- 0
- 1,275
- 0
- Cash & Bank
- 3,006
- 923
- Total Assets
- 6,496
- Total Debt
- 4
- Net Working Capital
- 4,611
- Contingent Liabilities
- 75
- Book Value per Share
- 359.30
- Face Value
- 1.00
- Total Debt
- 4
- Net Working Capital
- 4,611
- Contingent Liabilities
- 75
- Book Value per Share
- 359.30
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 16
- 7,128
- Trade Payables
- 463
- 226
- Total Liabilities
- 7,834
- 1,502
- Capital Work in Progress
- 181
- 155
- 1,186
- 0
- Cash & Bank
- 3,093
- 1,717
- Total Assets
- 7,834
- Total Debt
- 4
- Net Working Capital
- 5,270
- Contingent Liabilities
- 13
- Book Value per Share
- 434.84
- Face Value
- 1.00
- Total Debt
- 4
- Net Working Capital
- 5,270
- Contingent Liabilities
- 13
- Book Value per Share
- 434.84
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 16
- 7,941
- Trade Payables
- 587
- 233
- Total Liabilities
- 8,778
- 1,571
- Capital Work in Progress
- 177
- 0
- 1,945
- 0
- Cash & Bank
- 3,771
- 1,314
- Total Assets
- 8,778
- Total Debt
- 4
- Net Working Capital
- 6,172
- Contingent Liabilities
- 22
- Book Value per Share
- 483.12
- Face Value
- 1.00
- Total Debt
- 4
- Net Working Capital
- 6,172
- Contingent Liabilities
- 22
- Book Value per Share
- 483.12
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 16
- 8,706
- Trade Payables
- 768
- 1,121
- Total Liabilities
- 10,611
- 3,947
- Capital Work in Progress
- 238
- 0
- 1,655
- 1,559
- Cash & Bank
- 1,839
- 1,373
- Total Assets
- 10,611
- Total Debt
- 320
- Net Working Capital
- 4,247
- Contingent Liabilities
- 16
- Book Value per Share
- 529.56
- Face Value
- 1.00
- Total Debt
- 320
- Net Working Capital
- 4,247
- Contingent Liabilities
- 16
- Book Value per Share
- 529.56
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 16
- 9,134
- Trade Payables
- 820
- 1,202
- Total Liabilities
- 11,173
- 4,147
- Capital Work in Progress
- 151
- 0
- 1,685
- 1,517
- Cash & Bank
- 2,556
- 1,117
- Total Assets
- 11,173
- Total Debt
- 269
- Net Working Capital
- 5,218
- Contingent Liabilities
- 21
- Book Value per Share
- 555.40
- Face Value
- 1.00
- Total Debt
- 269
- Net Working Capital
- 5,218
- Contingent Liabilities
- 21
- Book Value per Share
- 555.40
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 16
- 10,296
- Trade Payables
- 834
- 1,302
- Total Liabilities
- 12,449
- 4,492
- Capital Work in Progress
- 342
- 0
- 1,744
- 1,891
- Cash & Bank
- 3,359
- 620
- Total Assets
- 12,449
- Total Debt
- 243
- Net Working Capital
- 5,918
- Contingent Liabilities
- 10
- Book Value per Share
- 625.91
- Face Value
- 1.00
- Total Debt
- 243
- Net Working Capital
- 5,918
- Contingent Liabilities
- 10
- Book Value per Share
- 625.91
- Face Value
- 1.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 701 | 605 | 791 | 364 | 997 | 915 | 1,031 | |
| Cash from Investing | -766 | -1,524 | -1,003 | 1,208 | -1,757 | 1,705 | 138 |
| Cash from Financing | -7 | 1,238 | 35 | 15 | -799 | -433 | -417 |
| -72 | 319 | -177 | 1,587 | -1,560 | 2,186 | 752 | |
| Free Cash Flow | 701 | 373 | 297 | 154 | -1,781 | 400 | -331 |
| OCF / Net Profit | 0.91 | 0.61 | 0.65 | 0.47 | 1.29 | 1.31 | 1.00 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -556 | -1,261 |
| OCF / Net Profit | 0.91 | 0.61 | 0.65 | 0.47 | 1.29 | 1.31 | 1.00 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -556 | -1,261 |
Mar 2020
- 701
- Cash from Investing
- -766
- Cash from Financing
- -7
- -72
- Free Cash Flow
- 701
- OCF / Net Profit
- 0.91
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.91
- Cumulative 5-Year FCF
- 0
Mar 2021
- 605
- Cash from Investing
- -1,524
- Cash from Financing
- 1,238
- 319
- Free Cash Flow
- 373
- OCF / Net Profit
- 0.61
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.61
- Cumulative 5-Year FCF
- 0
Mar 2022
- 791
- Cash from Investing
- -1,003
- Cash from Financing
- 35
- -177
- Free Cash Flow
- 297
- OCF / Net Profit
- 0.65
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.65
- Cumulative 5-Year FCF
- 0
Mar 2023
- 364
- Cash from Investing
- 1,208
- Cash from Financing
- 15
- 1,587
- Free Cash Flow
- 154
- OCF / Net Profit
- 0.47
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.47
- Cumulative 5-Year FCF
- 0
Mar 2024
- 997
- Cash from Investing
- -1,757
- Cash from Financing
- -799
- -1,560
- Free Cash Flow
- -1,781
- OCF / Net Profit
- 1.29
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.29
- Cumulative 5-Year FCF
- 0
Mar 2025
- 915
- Cash from Investing
- 1,705
- Cash from Financing
- -433
- 2,186
- Free Cash Flow
- 400
- OCF / Net Profit
- 1.31
- Cumulative 5-Year FCF
- -556
- OCF / Net Profit
- 1.31
- Cumulative 5-Year FCF
- -556
Mar 2026
- 1,031
- Cash from Investing
- 138
- Cash from Financing
- -417
- 752
- Free Cash Flow
- -331
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- -1,261
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- -1,261
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - |
| EPS (₹) | 49.88 | 60.94 | 73.75 | 47.42 | 46.90 | 42.40 | 62.35 |
| Book Value (₹) | 234.25 | 359.30 | 434.84 | 483.12 | 529.56 | 555.40 | 625.91 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 20.00 | 18.00 | 20.00 |
| Cash EPS (₹) | 55.98 | 66.98 | 80.46 | 56.33 | 67.82 | 65.33 | 88.07 |
| PROFITABILITY | - | - | - | - | - | - | - |
| Operating Margin % | 41.57% | 41.50% | 39.40% | 34.91% | 23.53% | 22.59% | 25.34% |
| Net Margin % | 29.35% | 28.79% | 27.53% | 21.55% | 13.64% | 12.44% | 15.98% |
| ROE % | 21.29% | 20.97% | 18.61% | 10.34% | 9.26% | 7.82% | 10.56% |
| ROCE % | 27.39% | 28.00% | 24.85% | 14.04% | 13.63% | 11.97% | 14.96% |
| 18.91% | 18.84% | 16.91% | 9.40% | 7.97% | 6.41% | 8.70% | |
| EFFICIENCY | - | - | - | - | - | - | - |
| Debtor Days | 83 | 67 | 72 | 98 | 78 | 100 | 97 |
| Inventory Days | 105 | 107 | 102 | 158 | 116 | 109 | 97 |
| Payable Days | 109 | 97 | 74 | 114 | 114 | 139 | 135 |
| 79 | 78 | 100 | 142 | 80 | 70 | 59 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.04x | 0.03x | 0.02x |
| Interest Coverage (x) | 139.24x | 392.33x | 309.77x | 142.61x | 44.23x | 26.30x | 45.01x |
| 7.93x | 10.00x | 10.05x | 9.46x | 4.04x | 4.33x | 4.68x | |
| GROWTH | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 31.51% | 27.08% | -17.64% | 56.29% | -0.85% | 14.50% |
| Operating Profit Growth % | 0.00% | 31.28% | 20.67% | -27.04% | 18.82% | -1.38% | 31.25% |
| Net Profit Growth % | 0.00% | 29.00% | 21.54% | -35.54% | -1.10% | -9.57% | 47.07% |
| 0.00% | 0.00% | 0.00% | 0.00% | -1.10% | -9.60% | 47.07% | |
| VALUATION | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 39.27x | 37.55x | 27.22x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 3.48x | 2.87x | 2.71x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 1.09% | 1.13% | 1.18% |
| 0.00x | 0.00x | 0.00x | 0.00x | 19.17x | 16.15x | 12.77x |
Mar 2020
- EPS (₹)
- 49.88
- Book Value (₹)
- 234.25
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 55.98
- Operating Margin %
- 41.57%
- Net Margin %
- 29.35%
- ROE %
- 21.29%
- ROCE %
- 27.39%
- 18.91%
- Debtor Days
- 83
- Inventory Days
- 105
- Payable Days
- 109
- 79
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 139.24x
- 7.93x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 60.94
- Book Value (₹)
- 359.30
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 66.98
- Operating Margin %
- 41.50%
- Net Margin %
- 28.79%
- ROE %
- 20.97%
- ROCE %
- 28.00%
- 18.84%
- Debtor Days
- 67
- Inventory Days
- 107
- Payable Days
- 97
- 78
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 392.33x
- 10.00x
- Revenue Growth %
- 31.51%
- Operating Profit Growth %
- 31.28%
- Net Profit Growth %
- 29.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 73.75
- Book Value (₹)
- 434.84
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 80.46
- Operating Margin %
- 39.40%
- Net Margin %
- 27.53%
- ROE %
- 18.61%
- ROCE %
- 24.85%
- 16.91%
- Debtor Days
- 72
- Inventory Days
- 102
- Payable Days
- 74
- 100
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 309.77x
- 10.05x
- Revenue Growth %
- 27.08%
- Operating Profit Growth %
- 20.67%
- Net Profit Growth %
- 21.54%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 47.42
- Book Value (₹)
- 483.12
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 56.33
- Operating Margin %
- 34.91%
- Net Margin %
- 21.55%
- ROE %
- 10.34%
- ROCE %
- 14.04%
- 9.40%
- Debtor Days
- 98
- Inventory Days
- 158
- Payable Days
- 114
- 142
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 142.61x
- 9.46x
- Revenue Growth %
- -17.64%
- Operating Profit Growth %
- -27.04%
- Net Profit Growth %
- -35.54%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 46.90
- Book Value (₹)
- 529.56
- Dividend per Share (₹)
- 20.00
- Cash EPS (₹)
- 67.82
- Operating Margin %
- 23.53%
- Net Margin %
- 13.64%
- ROE %
- 9.26%
- ROCE %
- 13.63%
- 7.97%
- Debtor Days
- 78
- Inventory Days
- 116
- Payable Days
- 114
- 80
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- 44.23x
- 4.04x
- Revenue Growth %
- 56.29%
- Operating Profit Growth %
- 18.82%
- Net Profit Growth %
- -1.10%
- -1.10%
- P/E (x)
- 39.27x
- P/B (x)
- 3.48x
- Dividend Yield %
- 1.09%
- 19.17x
Mar 2025
- EPS (₹)
- 42.40
- Book Value (₹)
- 555.40
- Dividend per Share (₹)
- 18.00
- Cash EPS (₹)
- 65.33
- Operating Margin %
- 22.59%
- Net Margin %
- 12.44%
- ROE %
- 7.82%
- ROCE %
- 11.97%
- 6.41%
- Debtor Days
- 100
- Inventory Days
- 109
- Payable Days
- 139
- 70
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 26.30x
- 4.33x
- Revenue Growth %
- -0.85%
- Operating Profit Growth %
- -1.38%
- Net Profit Growth %
- -9.57%
- -9.60%
- P/E (x)
- 37.55x
- P/B (x)
- 2.87x
- Dividend Yield %
- 1.13%
- 16.15x
Mar 2026
- EPS (₹)
- 62.35
- Book Value (₹)
- 625.91
- Dividend per Share (₹)
- 20.00
- Cash EPS (₹)
- 88.07
- Operating Margin %
- 25.34%
- Net Margin %
- 15.98%
- ROE %
- 10.56%
- ROCE %
- 14.96%
- 8.70%
- Debtor Days
- 97
- Inventory Days
- 97
- Payable Days
- 135
- 59
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 45.01x
- 4.68x
- Revenue Growth %
- 14.50%
- Operating Profit Growth %
- 31.25%
- Net Profit Growth %
- 47.07%
- 47.07%
- P/E (x)
- 27.22x
- P/B (x)
- 2.71x
- Dividend Yield %
- 1.18%
- 12.77x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-17 - Gland Pharma Limited has informed the Exchange about Transcript
- Appointment
2026-08-14 - Gland Pharma Limited has informed the Exchange regarding Appointment of Mr Deepak Sapra as Chief Executive Officer of the company w.e.f. November 16, 2026.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Feb 2026